Luisa
Luisa Andruzzi, Beverly, MA US
Patent application number | Description | Published |
---|---|---|
20130210991 | Hydrophilic Polymeric Particles and Methods for Making and Using Same - A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle. | 08-15-2013 |
20130211006 | Conjugated Polymeric Particle and Method of Making Same - A method of conjugating a substrate includes exchanging a counter ion associated with a biomolecule with a lipophilic counter ion to form a biomolecule complex, dispersing the biomolecule complex in a nonaqueous solvent, and coupling the biomolecule complex to a substrate in the presence of the nonaqueous solvent. | 08-15-2013 |
20140073715 | Hydrophilic Polymeric Particles and Methods for Making and Using Same - A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle. | 03-13-2014 |
20140073738 | Hydrophilic Polymeric Particles and Methods for Making and Using Same - A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle. | 03-13-2014 |
20140142254 | Hydrophilic Polymeric Particles and Methods for Making and Using Same - A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle. | 05-22-2014 |
Luisa Bertarione Rava Rossa, Pavone Canaverse IT
Patent application number | Description | Published |
---|---|---|
20110052493 | USE OF POLYPEPTIDES OBTAINED THROUGH SYSTEMATIC MUTATIONS OF SINGLE AMINO ACIDS OF HUMAN AND NON-HUMAN BOX-A OF HMGB1 TO PREVENT AND/OR ANTAGONIZE PATHOLOGIES INDUCED BY HMGB1 - The present invention relates to polypeptide variants of the HMGB-1 high affinity binding domain Box-A (HMGB1 Box-A) or to a biologically active fragment of HMGB1 Box-A, which are obtained through systematic mutations of single amino acids of the wild-type HMGB1 Box-A protein and which show an increased resistance to proteases and which are therefore characterized by more favourable pharmacokinetic and pharmacodynamic profiles. Moreover, the present invention concerns the use of said polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1 and associated with RAGE. | 03-03-2011 |
Luisa Bertarione Rava Rossa, Pavone Canavese (to) IT
Patent application number | Description | Published |
---|---|---|
20090191253 | Use of K-252a and Kinase Inhibitors for the Prevention or Treatment of HMGB1-Associated Pathologies - The present invention relates to the use of K-252a, a physiologically active substance produced by microorganisms, and of its salts or synthetic and/or chemically modified derivatives for the prevention or treatment of HMGB1 associated pathologies. More particularly, the present invention relates to the use of K-252a for the prevention or treatment of restenosis. | 07-30-2009 |
Luisa Bertarione Rava Rossa, Torino IT
Patent application number | Description | Published |
---|---|---|
20110311451 | SYNTHESIS OF POLYMER CONJUGATES OF INDOLOCARBAZOLE COMPOUNDS - The present invention relates to a process for the preparation of polymer conjugates of iπdolocarbazole compounds, in particular of polymer conjugates of K-252a and derivatives thereof, by a synthetic route which results in a highly pure product, with a high product yield. In a further aspect the present invention relates to novel polymer conjugates of K-252a and derivatives thereof, wherein the chemical group linking the polymer unity to the K-252a or to the K-252a derivative compound is characterised by a 5-member oxazolidindionic cyclic structure. These novel polymer conjugates are obtained through the novel synthetic route with high purity and high yields, | 12-22-2011 |
Luisa Bofinger, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20130313382 | STAND FOR A MEDICAL DEVICE - The invention relates to a stand for a medical device. The stand includes a first support arm and a second support arm, which is connected to the first support arm via a first joint connection having a first degree of freedom of motion and on which the medical device can be held. The first joint connection has a first switching device, which can be put into a first switching state and into a second switching state, wherein, in the first switching state, the first degree of freedom of motion is blocked or disabled and wherein, in the second switching state, the first degree of freedom of motion is open or enabled. | 11-28-2013 |
Luisa Borello, Torino IT
Patent application number | Description | Published |
---|---|---|
20120135326 | BACK-UP FUEL CELL ELECTRIC GENERATOR COMPRISING A COMPACT MANIFOLD BODY, AND METHODS OF MANAGING THE OPERATION THEREOF - A fuel cell electric generator designed for back-up in the absence of network electricity supply. The generator comprises a fuel cell stack, means for supplying the stack with a first and a second reagent flow comprising, in turn, pressure reducing means, and a manifold body to communicate with the stack said first and second reagent flows and at least a flow of coolant fluid via a respective coolant loop. The manifold body comprises inside chambers for the mixing of said reagent flows with corresponding re-circulated product flows and a coolant fluid expansion chamber within which said pressure reducing means of said first and second reagent flows are positioned at least partially drowned by said coolant. Method for the start-up and shut-down of the generator, and a method for detecting the flooding of a fuel cell and a method for detecting the presence of gas leakages in the generator are also disclosed. | 05-31-2012 |
Luisa Borello, Collegno IT
Patent application number | Description | Published |
---|---|---|
20080292928 | METHOD FOR PURGING PEM-TYPE FUEL CELLS - A method for purging water or another fluid from one or both the anode and cathode compartments of a fuel cell stack is presented. The stack is hydraulically connected to a source of reagents and to an outlet conduit, which is in its turn connected to a drain or a recirculator. At least one flow of reagents is regulated by a regulator and is sent from the source to the stack to produce electric power to be supplied to a user. The method includes interrupting withdrawal of current from the fuel cell stack and to the user by feeding the latter by an auxiliary source of electric energy such as to satisfy, on its own, electric energy requirements of the user. The method also includes simultaneously continuing to feed the at least one flow of reagents to the stack until the stack is purged to a desired extent. | 11-27-2008 |
Luisa Bortesi, Aachen DE
Patent application number | Description | Published |
---|---|---|
20150052638 | AGROBACTERIUM FOR TRANSIENT TRANSFECTION OF WHOLE PLANTS - A process of transiently transfecting a plant or leaves on a plant, comprising contacting said plant or said leaves with a suspension comprising | 02-19-2015 |
Luisa Cacheaux, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20120058949 | Methods of Treating Neurological Disorders - The present invention provides methods of treating epilepsy and other neurological disorders. The methods generally involve administering to an individual in need thereof an effective amount of an agent that blocks a transforming growth factor-beta pathway. | 03-08-2012 |
Luisa Ciobanu, Le Pecg FR
Patent application number | Description | Published |
---|---|---|
20090088626 | SYSTEM AND METHOD FOR PROVIDING FLOW-ENHANCED SIGNAL INTENSITY DURING A FUNCTIONAL MRI PROCESS - A method for imaging a brain of a subject includes providing a cognitive task for the subject or measuring resting state blood flow without a cognitive task, applying a saturation pulse sequence to saturate a slice within an imaging volume in the subject, and applying an imaging pulse sequence to acquire data from the imaging volume. A saturated image is acquired shortly after termination of the saturation pulse sequence and a non-saturation image is acquired after spins flowing through the saturated slice have recovered. The saturation image and the non-saturation image are subtracted to generate a blood velocity or perfusion enhanced difference image indicating portions of the brain active during the cognitive task. When measuring resting state blood flow without a cognitive task, the method includes acquiring a calibration scan and performing a quantitative evaluation of the blood velocity perpendicular to the saturated slice. | 04-02-2009 |
Luisa Daffonchio, L'Aquila IT
Patent application number | Description | Published |
---|---|---|
20120202884 | INHIBITORS OF CXCR1/2 AS ADJUVANTS IN THE TRANSPLANT OF PANCREATIC ISLETS - The invention relates to CXCR1 and/or CXCR2 inhibitors for the preparation of a medicament for use as an adjuvant in the transplant of pancreatic islets in Type 1 diabetes patients. In particular, the compounds that can be used according to the invention have the following formula (I) in which R and R′ are as defined in the description. | 08-09-2012 |
20130059908 | SULFONAMIDES FOR THE PREVENTION OF DIABETES - The use of sulfonamides of formula (I) wherein R and R | 03-07-2013 |
Luisa De Cola, Münster DE
Patent application number | Description | Published |
---|---|---|
20110187265 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PREPARATION THEREOF AND RADIATING COMPONENT - A phosphorescent metal complex compound, a method for the preparation thereof and a radiation component, in particular an organic light emitting electrochemical cell (OLEEC) use a bidentate ligand containing a triazole unit. Some of the blue emitters shown here for the first time, in particular the class of iridium complex compounds presented here, are the bluest emitters that have ever existed. | 08-04-2011 |
Luisa De Cola, Muenster DE
Patent application number | Description | Published |
---|---|---|
20120169213 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND RADIATION EMITTING STRUCTURAL ELEMENT - A phosphorescent metal complex may include at least one metallic central atom M; and at least one ligand coordinated by the metallic central atom, wherein one ligand is bidentate with two uncharged coordination sites and comprises at least one carbene unit coordinated directly to the metal atom. | 07-05-2012 |
Luisa De Cola, Munster DE
Patent application number | Description | Published |
---|---|---|
20100003188 | METHOD FOR INTERCALATING CHROMOPHORES INTO ZEOLITE-L NANOCHANNELS AND PRODUCTS THEREOF - The present invention discloses a method for the intercalation of a chromophore within channels of a zeolite L crystal. The intercalated chromophores exhibit J type aggregation of the chromophores within the channels of the zeolite L crystals. The invention discloses method parameters which lead to the J type aggregation of the chromophores within the channels of the zeolite L crystals. The J type aggregation of the chromophores affords unique florescent properties rendering the intercalated zeolite L crystals as a material for use in novel optoelectronic devices. | 01-07-2010 |
20100062417 | ZEOLITE CRYSTALS WITH BIOLOGICAL MATERIAL - The invention provides a hybrid construct comprising at least a zeolite crystal and at least one biological moiety such as for example a cells bacteria or virus and a method for the production thereof. | 03-11-2010 |
20100113554 | MANUFACTURE AND PRODUCTS THEREOF OF PHOTOSENSITIZING NANOMATERIALS AND THEIR USE IN PHOTODYNAMIC TREATMENT - A method for the manufacture of a photosensitizing nanomaterial ( | 05-06-2010 |
20100252820 | LIGHT EMITTING CU (I) COMPLEXES - Electroneutral metal complexes of the formula L Cu A, wherein L stands for an, especially bidentate, neutral ligand and A stands for an, especially bidentate, monoanionic ligand binding to Cu by at least one heteroatom selected from N, P, S; or wherein the ligands L and A with the above features are interconnected by at least one chemical bond to form one common tetradentate ligand; or protonated or alkylated forms or salts thereof show good light emitting efficiency in electroluminescent applications. | 10-07-2010 |
20110177630 | COMPLEX SALTS - Disclosed is a salt of an organometallic complex cation and an organometallic complex anion, wherein the cation as well as the anion consists of a central metal atom M of atomic weight greater than 40 associated to 2 or more ligands, at least one ligand comprising a cyclic organic moiety with a carbon atom bonding to M, and at least one ligand comprising a cyclic organic moiety with a nitrogen atom bonding to M. The novel salts may be used as conductive and/or light emitting components in electronic devices. Color emission may be chosen by selecting anion(s) and cation(s) of suitable emission characteristics. | 07-21-2011 |
20110287408 | Preparation of Micro-Porous Crystals and Conjugates Thereof - A conjugate comprising a dye-labeled microporous crystal, a stop-cock moiety, and covalently bound thereto an affinity binding agent is disclosed. The dye-labeled microporous crystal is a zeolite crystal, such as a zeolite L crystal, having a large number of channels in its interior into which the dye is loaded. The stop-cock moiety can be functionalized with an amino group to which a carboxyester group can be attached. The affinity binding agent allows for the binding to a biological moiety. The conjugate of the moiety can be used in in-vivo and/or in-vitro imaging applications. | 11-24-2011 |
20130004986 | Use of luminescent Ir(III) and Ru(II) complexes - The present invention relates to the use of luminescent Ir(III) and Ru(II) complexes and their application in electro-chemiluminescence and bio-labelling. The use refers to the labelling and detection of biomolecules. | 01-03-2013 |
20130046096 | Phosphorescent Metal Complex, Process for Production and Light-Emitting Component - This invention presents, firstly, the principle that simple and known emitter materials which are uncharged per se, as known, for example, from OLED technology, can be converted to a charged species by the introduction of a charged imidazolinium radical. This charged species can then be used in organic light-emitting electrochemical cells. | 02-21-2013 |
Luisa De Cola, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20130323719 | NEW IRIDIUM-BASED COMPLEXES FOR ECL - Novel iridium-based Ir(III) luminescent complexes, conjugates comprising these complexes as a label and their application, for example in the electrochemiluminescence based detection of an analyte. | 12-05-2013 |
20130323857 | NEW IRIDIUM-BASED COMPLEXES FOR ECL - Novel iridium-based Ir(III) luminescent complexes, conjugates comprising these complexes as a label and their application, for example in electrochemiluminescence based detection of an analyte. | 12-05-2013 |
20140088307 | Platinum Complexes and Their Use - The invention relates to platinum complexes and their use in biomedical applications, like in vitro and in vivo imaging and cell staining. The present invention provides new materials and their use as imaging agent. The formation of luminescent aggregates can allow a switch of the emission leading to a dynamic label and on the formation of soft assemblies, which, in some cases, are even more emissive than the isolated corresponding species | 03-27-2014 |
Luisa Filipponi, Aarhus DK
Patent application number | Description | Published |
---|---|---|
20090270276 | BEAD IMMOBILISATION METHOD AND BEAD ARRAYS MADE THEREBY - A bead immobilization method including receiving at least one bead in at least one well in a casting surface, and casting a casting material over the casting surface to form a reverse casting in which the at least one bead is cast onto at least one post upstanding from a surface of the reverse casting. | 10-29-2009 |
Luisa Gambelli, Wormerveer NL
Patent application number | Description | Published |
---|---|---|
20090203780 | Use of a Polyunsaturated Fatty Acid Compound - A polyunsaturated fatty acid having 20 carbon atoms and four double bonds, or a derivative thereof, in an orally administrable form, can be used to treat or prevent obesity and/or for weight management. The polyunsaturated fatty acid may, for example, be used in the form of a food supplement, a pharmaceutical composition or a food composition. | 08-13-2009 |
Luisa Gao, Taipei City TW
Patent application number | Description | Published |
---|---|---|
20110315754 | FOLDABLE PAPER BOX - A foldable paper box includes an inner panel that has an inner base wall secured to an outer base wall of an outer panel, two first inner sidewalls and two second inner sidewalls connected foldably to the inner base wall to confine a receiving space that is closed by a cover wall of the outer panel. The outer and inner base walls confine therebetween two insert slots adjacent to the first inner sidewalls. The first inner sidewalls are insertable partially into respective insert slots after being folded to extend uprightly from the inner base wall. The second inner sidewalls are inserted partially and non-removably in between the inner and outer base walls and secured to the outer base wall after being folded. | 12-29-2011 |
Luisa Gennero, Torino IT
Patent application number | Description | Published |
---|---|---|
20080311625 | Immortal Pluripotent Stem Cell Line, Cell Lines Derived Therefrom, Methods of Preparing Thereof and Their Uses - The present invention relates to immortal pluripotent stem cells derived from a human leukaemia cell line, preferably a human monocytoid cell line and more preferably the human monocytoid cell line, THP1. The present invention further relates to cell lines derived from the immortal pluripotent stem cell line having the phenotype of cell strains characteristic of human tissues, particularly having a human hepatocyte phenotype, as well as the methods for preparing thereof. The present invention further relates to the use of the derived cell line with a human hepatocytic phenotype for the production of albumin and blood coagulation factors. | 12-18-2008 |
20080317730 | Compositions Useful for Recovering Original Trophism and Pigmentation, and for Stimulating Growth of the Integumentary Apparatus, Uses and Products Thereof - The present invention relates to compositions and products comprising at least one proteolytic enzyme adapted to promoting the restoration of original trophism of the integumentary apparatus, the original pigmentation and stimulating the growth thereof and, particularly, improving the viability of the pilifer follicles, even in scar tissue areas. | 12-25-2008 |
20090181007 | CULTURE MEDIUM AND PHARMACEUTICAL COMPOSITION FOR REGENERATING CARTILAGE TISSUE, A METHOD, USES AND PRODUCTS RELATED THERETO - A composition for in vitro use as a culture medium or in vivo use as a pharmaceutical composition or a medical device, capable of accelerating the differentiation of stem cells into cells with a chondrocytic phenotype and of restoring the original trophism of chondrocytes, is described. The composition comprises, in combination, at least one proteolytic enzyme, at least one growth factor and at least one from a sugar, an amino acid, a vitamin factor, a vitamin, a nucleotide and a nucleoside, in a physiologically acceptable carrier or diluent. A method of differentiating stem cells in cells having a chondrocytic phenotype, the cells obtained by the method and their uses, for example in human or animal cell therapy, for example by CBMP (Cellular Based Medicinal products) are also described. | 07-16-2009 |
20100092454 | NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS - What is described is a use of an antidepressant compound, preferably belonging to the class of selective serotonin reuptake inhibitors (SSRI), for regenerating the integumentary system and/or for stimulating the growth, the original trophism and/or original pigmentation of the corresponding cutaneous appendages, particularly body hair and/or head hair, in mammals. For this purpose, the antidepressant can be formulated in a cosmetic preparation, a pharmaceutical composition, a medical device, or in the form of a culture medium, alone or in combination with a further active ingredient such as a proteolytic enzyme and/or a vitamin. | 04-15-2010 |
20100130544 | USE OF PARASYMPATHOLYTIC SUBSTANCES TO ENHANCE AND ACCELERATE STEM CELL DIFFERENTIATION, RELATED METHODS AND COMPOSITIONS - The invention refers to the in vitro and in vivo use of parasympatholytic substances, preferably scopolamine, to potentiate and accelerate the differentiation of stem cells into cells with a tissue-specific phenotype, and the process and compositions related thereto. | 05-27-2010 |
20100310544 | COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES - The invention is based on the finding that calcium ions and proteolytic enzymes, particularly papain, act in a synergetic way in the regeneration of skin and connective tissues. Thus, such a combination of active principles can be used for the preparation of culture media for cutaneous and/or connective tissue biopsies, which allow for the maintenance of the biopsies under viable conditions for periods of over 6 months, even for over 3 years, as well as for the preparation of pharmaceutical compositions or medical devices for the treatment of diseases in which the regeneration of cutaneous and connective tissues is beneficial (for instance, injuries and wounds, keloids, paradontopathies, conjunctivitis, nasal and ear polyps, cellulite, human and animal dermatitis), and for the preparation of cosmetic compositions that in particular have an anti-ageing effect on the skin. | 12-09-2010 |
20110045519 | DIFFERENTIATED IMMORTALISED CELL LINES CAPABLE OF PRODUCING ALBUMIN AND BLOOD COAGULATION FACTORS, METHODS OF PREPARING THEREOF FROM A LEUKAEMIA CELL LINE AND USES THEREOF - The invention relates to cell lines from differentiated cells with hepatocytic phenotypes capable of producing albumin and blood coagulation factors, said cells being derived from a human leukaemia cell line, preferably the human THP1 cell line, and preserving the characteristics of immortality. Among the cell lines of the invention, the cell lines known as PSC-THP1-EP, PSC-THP1-EP-FAST, PSC-THP1-HEP and PSC-THP1-EPEP are preferred. The invention also relates to methods for obtaining the cell lines of the invention and the uses of said cell lines, particularly for the production of albumin and/or blood coagulation factors. | 02-24-2011 |
20110206732 | ALBUMIN FOR TREATING CANCER AND A PHARMACEUTICAL COMPOSITION COMPRISING THE COMBINATION OF AN ANTI-NEOPLASTIC AGENT AND ALBUMIN - The present invention relates to albumin as an active ingredient in a medicament for the treatment of cancer and to a pharmaceutical composition comprising at least one anti-neoplastic agent and albumin at a concentration of at least 2% w/v of the composition, in a pharmaceutically acceptable vehicle. The anti-neoplastic agent is preferably hydroxyurea, preferably at concentration between 10 μM and 1 mM, more preferably between 10 μM and 100 μM. The pharmaceutical composition of the invention is effective in the therapeutic treatment of cancer and advantageously shows reduced side effects in comparison with the administration of the anti-neoplastic agent alone. | 08-25-2011 |
20130122091 | POLYDEOXYRIBONUCLEOTIDE-BASED COMPOSITIONS AND THEIR METHODS OF USE - Compositions including synergistic combinations of polydeoxyribonucleotides and methyl amides, such as carnitine, are provided. Such compositions may include further optional active ingredients, such as a calcium salt, vitamins of the D or B groups, a sodium salt and a potassium salt, preferably used in combination. | 05-16-2013 |
20130287757 | COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES - An effective composition is for the therapeutic or cosmetic treatment of atrophic cutaneous and subcutaneous tissues, skin appendages, connective tissues or mucous tissues. The composition includes a combination of a salt of adamantane carboxylic acid, preferably salified with an aromatic and/or adamantane base, with a proteolytic enzyme and/or willow extract, salicylic acid, acetylsalicylic acid, salicylate, or acetylsalicylate. Further active ingredients that are suitable for inclusion in the composition are zinc oxide, vitamins, phytoextracts, sugars, amino acids, minerals, further salts, phytoextracts, ventilated green clay and any combination thereof. The composition has a particular synergy between the constituent elements, and is particularly effective in the treatment of atrophic ulcers or bedsores. | 10-31-2013 |
Luisa Gudino, Downingtown, PA US
Patent application number | Description | Published |
---|---|---|
20090211920 | SYSTEM FOR MAINTAINING HYDROGEN PURITY IN ELECTRICAL GENERATORS AND METHOD THEREOF - A method and apparatus is provided for a system for maintaining hydrogen purity in an electrical power generator. The purity system includes: a generator, a hydrogen generator configured to provide hydrogen gas to the generator, a purity monitor for detecting the level of hydrogen purity in the generator and providing a signal when the purity drops below a predetermined threshold. The system automatically compensates for gas loss or contamination to maintain the desired level of efficiency in the electrical generator. | 08-27-2009 |
Luisa Iruela-Arispe, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20080312146 | METH1 and METH2 Polynucleotides and Polypeptides - The present invention relates to novel anti-angiogenic proteins, related to thrombospondin. More specifically, isolated nucleic acid molecules are provided encoding human METH1 and METH2. METH1 and METH2 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for the prognosis of cancer and therapeutic methods for treating individuals in need of an increased amount of METH1 or METH2. Also provided are methods for inhibiting angiogenesis using METH1 or METH2. | 12-18-2008 |
Luisa Izzi, Montreal CA
Patent application number | Description | Published |
---|---|---|
20140079713 | MODULATION OF THE SONIC HEDGEHOG PATHWAY AND USES THEREOF - A method for modulating Sonic hedgehog (Shh)-mediated signalling and proliferation based on agents that modulates the binding of GAS1, BOC and/or CDON to Ptch1 is disclosed. Methods and compositions for treating cancer using agents that inhibit the binding of GAS1, BOC and/or CDON to Ptch1 are also disclosed. Methods for identifying agents that may be used to inhibit Shh-mediated signalling/proliferation and cancer based on their capacity to inhibit the binding of GAS1, BOC and/or CDON to Ptch1 are also disclosed. | 03-20-2014 |
Luisa Laureti, Issy Les Moulineaux FR
Patent application number | Description | Published |
---|---|---|
20120142622 | STAMBOMYCIN AND DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS DRUGS - The present invention relates to Stambomycin compounds, their derivatives and their pharmaceutically acceptable salt thereof. | 06-07-2012 |
Luisa Lopez-Ochoa, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20080289065 | Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses - Polypeptides and fusion proteins that bind to eukaryotic viruses, in particular, eukaryotic single-stranded DNA (ssDNA) viruses are provided. The polypeptides and fusion proteins bind to the replication initiation proteins (Rep) of ssDNA viruses and optionally inhibit viral replication and/or viral infection. The virus can be a plant pathogen or animal pathogen. Consensus sequences used to identify polypeptides that bind to eukaryotic viruses are also provided. | 11-20-2008 |
20120220519 | Peptide Aptamers that Bind to the Rep Proteins of ssDNA Viruses - Polypeptides and fusion proteins that bind to eukaryotic viruses, in particular, eukaryotic single-stranded DNA (ssDNA) viruses are provided. The polypeptides and fusion proteins bind to the replication initiation proteins (Rep) of ssDNA viruses and optionally inhibit viral replication and/or viral infection. The virus can be a plant pathogen or animal pathogen. Consensus sequences used to identify polypeptides that bind to eukaryotic viruses are also provided. | 08-30-2012 |
Luisa Mª Luisa Astudillo Campillo, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130095249 | ANTI-GRAFFITI EMULSIONS WITH ANTI-HUMIDITY BARRIER CHARACTERISTIC - The present invention relates to anti-graffiti emulsions comprising at least one type of wax, oil, additives and at least one medium or carrier. Additionally, the present invention relates to a process for preparing an anti-graffiti emulsion, a method for application thereof and a method for cleaning and recovering the protective effect of graffiti-painted surfaces. Finally, the invention relates to the use of the anti-graffiti emulsion for any type of surface against graffiti and sticking of posters. | 04-18-2013 |
Luisa Mestroni, Boulder, CO US
Patent application number | Description | Published |
---|---|---|
20100298399 | Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy - The present invention concerns the use of methods for evaluating β-adrenergic receptor targeting agent treatment for a patient, particularly one with a heart condition. In general, the disclosed methods entail determining the presence or absence of one or more polymorphisms in an endothelin gene system member. Based on the results of this determination, a β-adrenergic receptor targeting agent may be prescribed, administered or a treatment regimen altered, including the administration of a β-blocker. Accordingly, methods of treatment are also described. | 11-25-2010 |
20140087461 | CARBON-NANOTUBE MODULATION OF MYOCYTE CELLS - Embodiments include compositions of carbon nanotubes complexed with myocyte cells. Embodiments also include methods for making compositions of carbon nanotubes, and methods for modulating the electrophysical, proliferative, and viability potential of myocytes. | 03-27-2014 |
Luisa Montesano-Roditis, Santa Manica, CA US
Patent application number | Description | Published |
---|---|---|
20090274375 | METHOD AND SYSTEM FOR ALIGNING AND CLASSIFYING IMAGES - In one embodiment, L dimensional images are trained, mapped, and aligned to an M dimensional topology to obtain azimuthal angles. The aligned L dimensional images are then trained and mapped to an N dimensional topology to obtain 2 | 11-05-2009 |
Luisa Montesano-Roditis, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20140072207 | METHOD AND SYSTEM FOR ALIGNING AND CLASSIFYING IMAGES - In one embodiment, L dimensional images are trained, mapped, and aligned to an M dimensional topology to obtain azimuthal angles. The aligned L dimensional images are then trained and mapped to an N dimensional topology to obtain 2 | 03-13-2014 |
Luisa Montinaro, Milano IT
Patent application number | Description | Published |
---|---|---|
20110259496 | TYRE COMPRISING AN ELECTRONIC UNIT - A tyre having an internal surface includes an electronic device and an anchoring body mounted on the internal surface for engagement between the electronic device and the internal surface of the tyre, wherein the anchoring body includes a crosslinked elastomeric material obtained by crosslinking a crosslinkable elastomeric composition including a synthetic diene rubber, preferably in an amount of from 20 to 80 phr, and a halogenated butyl rubber, preferably in an amount of from 80 to 20 phr. | 10-27-2011 |
Luisa Poggi, Banchette IT
Patent application number | Description | Published |
---|---|---|
20130096420 | Process For Preparing Hyperpolarized Substrates And Method For MRI - The present invention generally relates to a process for the preparation of aqueous solutions of hyperpolarized molecules ready for use in in-vivo MR diagnostic imaging, the use thereof as MRI contrast agent in investigation methods for producing diagnostic MR images of a human or non-human animal body organ, region or tissue. | 04-18-2013 |
Luisa Rizza, Santa Venerina (ct) IT
Patent application number | Description | Published |
---|---|---|
20110318432 | COMPOSITIONS FOR THE TREATMENT OF GASTRO-ESOFAGEAL REFLUX DISEASE (GERD) - Oral pharmaceutical, nutraceutical, health foods and medical device compositions based on polysaccharides from | 12-29-2011 |
20120183627 | COMPOSITIONS FOR THE TREATMENT OF HEMORRHOIDS AND RELATED DISEASES - The present invention relates to pharmaceutical, nutraceutical, health foods and medical device compositions comprising polysaccharides from | 07-19-2012 |
Luisa Ronga, Nola IT
Patent application number | Description | Published |
---|---|---|
20120101257 | PROCESSES FOR PREPARING AMINO-SUBSTITUTED GAMMA-LACTAMS - The present application describes general process for the preparation of amino-substituted gamma-lactams involving the reaction of synthons of the general Formulae (I) and (VI): with amines. The processes are amenable to solid phase synthetic techniques and therefore allow the efficient incorporation of amino-substituted gamma-lactams into a wide variety of structural scaffolds, including, in particular peptides. | 04-26-2012 |